Dartmouth’s Center For Technology & Behavioral Health Launches Collaboration With Boehringer Ingelheim To Develop Digital Health Tools For SMI

The Center for Technology and Behavioral Health (CTBH) at the Geisel School of Medicine at Dartmouth is collaborating with Boehringer Ingelheim with the goal of advancing prescription digital therapeutics that specifically target serious mental illness (SMI). The one-year collaboration, with the option for renewal, aims to combine CTBH’s pioneering research with Boehringer Ingelheim’s industry expertise.

The focus will be to create, study, and implement digital health solutions. The goal is to change how clinical professionals prescribe digital health tools to address mental and behavioral health conditions and improve the quality of life for people with SMI.

Boehringer . . .